Holen Sie sich die Stockscreener-App
17.04
8.19%
-1.52
Handel nachbörslich:
17.55
0.51
+2.99%
Schlusskurs vom Vortag:
$18.56
Offen:
$17.58
24-Stunden-Volumen:
43,561
Relative Volume:
1.63
Marktkapitalisierung:
$179.71M
Einnahmen:
$75.03M
Nettoeinkommen (Verlust:
$-7.71M
KGV:
-23.62
EPS:
-0.7214
Netto-Cashflow:
$-3.95M
1W Leistung:
+1.67%
1M Leistung:
-17.12%
6M Leistung:
+45.14%
1J Leistung:
+506.41%
1-Tages-Spanne:
$16.86
$18.00
1-Wochen-Bereich:
$15.83
$18.59
52-Wochen-Spanne:
$2.4866
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Firmenname
Burning Rock Biotech Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare BNR vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
17.04 | 195.74M | 75.03M | -7.71M | -3.95M | -0.7214 |
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Aktie (BNR) Neueste Nachrichten
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Risk Reward Ratio - newser.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Trading Down 9.7%Here's What Happened - MarketBeat
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Intel, Iris Energy among market cap stock movers on Friday By Investing.com - Investing.com Nigeria
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Intel and AMD among market cap stock movers on Friday - Investing.com
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Up 34.3% in December - MarketBeat
Burning Rock Announces Results of 2025 Annual General Meeting - ChartMill
Burning Rock Biotech (NASDAQ:BNR) Trading 0.1% HigherWhat's Next? - MarketBeat
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LSX:A40AE6 - TradingView
A40AE6 Stock Price and Chart — LSX:A40AE6 - TradingView
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LS:A40AE6 - TradingView
Burning Rock Stock Up 35%+ As Loss Narrows - Sahm
Wall Street analysts’ outlook for Acumen Pharmaceuticals Inc (ABOS) - setenews.com
Metals News and Commentary - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Barchart.com
Empowering Investor Success - Morningstar
BNR: Pharma R&D growth and cost controls drove higher margins and a reduced net loss in Q3 2025 - TradingView
BNR: 3Q25 saw positive cash flow, higher margins, and strong pharma R&D and overseas revenue growth - TradingView
Operating cash flow per share of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Its Stock Has Paid Off Big Time For Atlas Lithium Corporation - Setenews
Its Stock Has Paid Off Big Time For Strategy Inc - Setenews
It is Poised to be a Bull Market for HCM II Acquisition Corp (HOND) - Setenews
Burning Rock Biotech (NASDAQ:BNR) Trading 2.8% Higher – Time to Buy? - Defense World
HSG HOLDING LTD Institutional Portfolio - Nasdaq
A significant driver of top-line growth: Neonode Inc (NEON) - Setenews
Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Finviz
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
UK Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Dividend News and Commentary - Barchart.com
The United States Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - ChartMill
Saudi Arabia Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
symbol__ Stock Quote Price and Forecast - CNN
Recent Insider BuyingStock ScreenerSnapshot - Finviz
Finanzdaten der Burning Rock Biotech Ltd Adr-Aktie (BNR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):